An observational study in Pregnancy, sponsored by Bayer. Completed at 1 site in United States. Open to female participants aged 15 Years to 44 Years. Per ClinicalTrials.gov, last updated 2017-03-16.
Sponsored by Bayer · Observational
To assess the proportion of women who use HERC for ≥2 years of duration
Bayer is the lead sponsor of 1,643 studies on the registry; 57 are open to participants now.
Of its 209 completed or terminated interventional studies of FDA-regulated products, 129 (62%) have results posted.
Counted across the registry records on this site, refreshed daily.
Women who had an IUD or contraceptive implant inserted at the University of Utah healthcare system
Inclusion Criteria:
-Women who had an IUD or contraceptive implant inserted and removed within the University of Utah from January 1, 2004 to October 31, 2012
Women who had an insertion of HERC (Mirena IUD, ParaGard IUD, Implanon or Nexplanon)
Drug: Mirena (Levonorgestrel IUS, BAY86-5028) · Drug: ParaGard · Drug: Implanon/Nexplanon
Levonorgestrel-releasing intrauterine device 20 mcg/day
Copper T380A
Etonorgestrel contraceptive implant
Proportion of women who use HERC
Time frame: 2 years post-HERC initiation
Duration of real world use of three different HERC devices
Time frame: 2 years post-HERC initiation
Difference in patient characteristics of women who chose different HERC devices
Time frame: 2 years post-HERC initiation
Proportion of HERC used for ≥3 years of duration
Time frame: ≥3 years post-HERC initiation
Model the predictors of ≥3 years of duration
Time frame: ≥3 years post-HERC initiation
This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bayer